The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s office to remote, point-of-care coordinated sites in hospitals and multisite practices. Meet lab-quality testing standards with an analyzer that speeds and simplifies diabetes tests and delivers accurate, clinically relevant results shown to improve decision-making, patient compliance, and outcomes.

Features

Manage diabetes patients more effectively
Improve workflow in office or clinic
Simplify management of diabetes testing in decentralized settings
One of just two HbA1c analyzers that meet NGSP performance criteria
Used by three out of four physicians who perform HbA1c testing in their office

System Description	Point-of-care immunoassay analyzer
Quantitative Tests	Hemoglobin A1c (whole blood): Range: 2.5% to 14% (4mmol/mol to 130 mmol/mol) Microalbumin/Creatinine (urine): Single test reports all three results for: Albumin: 5 to 300 mg/L; Creatinine: 15 to 500 mg/dL (1.3 to 44.2 mmol/L); Albumin-to Creatinine Ratio: 1 to 2000 mg/g (0.11 to 226 mg/mmol)
Test Format	Self-contained immunoassay cartridges
Test Measurement	Automatic, optional transmission
Test Method	HbA1c: monoclonal antibody agglutination reaction
Time to Test Results	HbA1c – 6 minutes

DCA Vantage® Analyzer

California Prop 65

WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, visit Proposition 65